Alert: New State Bills & Congressional Language Introduced Impacting Psychedelic Commerce

New legislative activity is emerging at both state and federal levels. Connecticut SB00191 proposes modifications to its psychedelic-assisted therapy program, while West Virginia SB906 introduces a trigger law. Furthermore, Congressional appropriations bills now include language on psychedelic therapy, indicating increased federal attention. Merchants should closely track these developments as they may lead to new compliance requirements and market shifts.

Policy Round-Up:

New State Bills: Connecticut SB00191 seeks to modify the state’s psychedelic-assisted therapy program. West Virginia SB906 is introduced as a trigger law bill.
Congressional Signals: Congressional appropriations bills now incorporate language related to psychedelic therapy and its rollout, indicating growing federal engagement.
Colorado Developments: Colorado is advancing its Natural Medicine Program, focusing on real-world outcomes tracking.
National Sentiment: A RAND survey reveals 23% of Americans support legal psilocybin use, highlighting a notable segment of public support.

These legislative actions and discussions suggest an evolving landscape for psychedelic and natural medicine commerce.

Sentinel Insight